Beech Tree Labs Announces Positive Results for IND Phase 2 Oral Herpes Clinical Trials
July 21, 2015 09:10 ET
|
Beech Tree Labs, Inc.
PROVIDENCE, R.I., July 21, 2015 (GLOBE NEWSWIRE) -- Beech Tree Labs, Inc. announced today that it has completed its second Phase 2 clinical trial in which its candidate product BTL-tml was evaluated...
Beech Tree Labs Allowed Patent for COPD Therapy
December 02, 2014 09:10 ET
|
Beech Tree Labs, Inc.
PROVIDENCE, R.I., Dec. 2, 2014 (GLOBE NEWSWIRE) -- Beech Tree Labs, Inc. announced today that it received notice of allowance from the U.S. Patent and Trademark Office (USPTO) for a patent covering...
Beech Tree Labs Announces Successful Completion of IND Phase 1/2a Oral Herpes Clinical Trial
April 04, 2013 08:26 ET
|
Beech Tree Labs, Inc.
PROVIDENCE, R.I., April 4, 2013 (GLOBE NEWSWIRE) -- Beech Tree Labs, Inc. announced today that it has completed a Phase 1/2a clinical evaluation of its novel therapeutic agent, BTL-TML-HSV, for...